| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.009 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.32 | 0.009 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |